Kelsey Ramsden on MINDCURE iSTRYM Beta and Commercial Distribution
Marijuana Stocks, Finance, & InvestingUncategorized September 1, 2021 MJ Shareholders
After our July interview with CEO Kelsey Ramsden about the company’s Ibogaine synthesis, August brought more exciting announcements for Mind Cure Health Inc (CNSX: MCUR) (OTCMKTS: MCURF). Ramsden joins us once more to talk about the beta release of iSTRYM things to look forward to for Mind Cure in Q4 and beyond.
Here’s some highlights from the interview.
Beta release of iSTRYM proof that Mind Cure delivers to investors
The beta version of iSTRYM has been released, and full commercial distribution is expected in Q1 of 2022.
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
